Nurse well-being When Health Care Is Woven in Our Family Fabric, We Find Support in Unexpected Places March 07, 2024
nursing professional development OCN® Certification Test-Taking Tips to Ease Your Anxiety February 15, 2024
Oncology nurse-patient relationship Oncology Nurses Help Patient Find Her Music Again December 22, 2023
Interprofessional teams Holiday Traditions Contribute to a Positive Workplace Culture December 15, 2023
Nurse well-being ONS Members Tell Us About the Inspirational Nurses Who’ve Shaped Their Careers November 23, 2023
Trending Topics Research Safety COVID-19 Drug Reference Sheets Specific Populations ONS Congress Newscast View All Topics
Survivorship Opioid-Related Death Rates Are Increasing, But Less So in Cancer Survivors July 16, 2020
Press Releases ONS Offers Companies the Oncology Nursing Society Seal of Approval™ to promote Oncology Nurse and Patient Support Materials July 13, 2020
Survivorship Myeloproliferative Neoplasm Symptoms, Diagnosis, Treatment, and Survivorship Recommendations July 09, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Oral Combination of Decitabine and Cedazuridine for Myelodysplastic Syndromes July 08, 2020
Cancer research Prostate Cancer Clinical Trials Don’t Reflect Racial Diversity—And It’s Getting Worse Over Time July 08, 2020
Cancer healthcare advocacy All Politics Is Local, and That’s Why You Should Get Involved in ONS Advocacy July 06, 2020
Oncology drug research FDA Approves Avelumab for Urothelial Carcinoma Maintenance Treatment July 02, 2020
Cancer research Antibody-Drug Conjugates Join the Best of Two Worlds Into One New Treatment July 01, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Pembrolizumab for First-Line Treatment of MSI-H/dMMR Colorectal Cancer June 30, 2020
Oncology drug research FDA Approves Combination of Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf for HER2-Positive Breast Cancer June 30, 2020
Oncology drug research FDA Approves Pembrolizumab for Treatment of Cutaneous Squamous Cell Carcinoma June 25, 2020
COVID-19 Cancer Consortium Report Reveals High Mortality Rates in Patients With COVID-19 and Cancer June 25, 2020
Oncology drug research FDA Approves Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma June 23, 2020
U.S. Food and Drug Administration (FDA) HIV-Positive Patients With Cancer Need to Be Included in Clinical Drug Trials June 23, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Tazemetostat for Follicular Lymphoma June 19, 2020
Chemotherapy Polypharmacy Before Cancer Is Predictive of Post-Treatment Hospitalization June 19, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Pembrolizumab for Patients With TMB-H Solid Tumors June 17, 2020
U.S. Food and Drug Administration (FDA) FDA Extends Indication for Gemtuzumab Ozogamicin for CD33-Positive AML in Pediatric Patients June 16, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Lurbinectedin for Metastatic Small Cell Lung Cancer June 16, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Nivolumab for Esophageal Squamous Cell Carcinoma June 11, 2020
Press Releases ONS Virtual Conference Bridges the Gap Between Education and Practice Change June 10, 2020
Clinical practice Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations June 09, 2020
ONS Leadership For 2021, ONS Election Recruitment Goes Virtual, Congress Fees Remain Level June 08, 2020
Oncology drug research FDA Approves Ramucirumab Plus Erlotinib for First-Line Treatment of Metastatic NSCLC June 01, 2020